Trials / Completed
CompletedNCT02604654
Effectiveness and Safety of Yiqitongluo Granule for Stroke
Phase IV Clinical Trial of Yiqitongluo Granule in the Treatment of Stroke With Qi-deficiency and Blood-stasis Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,197 (actual)
- Sponsor
- Yi Yang · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the prospective study is to evaluate the effectiveness and safety of Yiqitongluo granule in the treatment of stroke with qi-deficiency and blood-stasis in more than sixy hospitals all over China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yiqitongluo granule | administered after dissolved |
Timeline
- Start date
- 2015-12-29
- Primary completion
- 2017-11-05
- Completion
- 2017-12-06
- First posted
- 2015-11-13
- Last updated
- 2021-08-25
Source: ClinicalTrials.gov record NCT02604654. Inclusion in this directory is not an endorsement.